Published in Br J Ophthalmol on March 01, 1991
Development of atrophy of the retinal pigment epithelium around disciform scars. Br J Ophthalmol (2006) 1.01
Bilateral involvement by age related maculopathy lesions in a population. Br J Ophthalmol (1998) 0.92
The symmetry of phenotype between eyes of patients with early and late bilateral age-related macular degeneration (AMD). Graefes Arch Clin Exp Ophthalmol (2010) 0.83
Asymmetry of disciform scarring in bilateral disease when one eye is treated with radiotherapy. Br J Ophthalmol (1995) 0.82
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol (1981) 7.05
Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol (1983) 6.20
Senile macular degeneration: a case-control study. Am J Epidemiol (1983) 3.04
The development of neovascularization of senile disciform macular degeneration. Am J Ophthalmol (1973) 2.17
Senile disciform macular degeneration in the second eye. Br J Ophthalmol (1977) 2.07
The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci (1986) 1.90
Prognosis of patients with bilateral macular drusen. Ophthalmology (1984) 1.73
Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology (1986) 1.62
Senile disciform macular degeneration: features indicating suitability for photocoagulation. Br J Ophthalmol (1979) 1.54
Visual results with low-vision aids in age-related macular degeneration. Am J Ophthalmol (1988) 1.40
Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity. Arch Ophthalmol (1986) 1.35
Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina (1988) 1.33
Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol (1987) 1.16
The prevalence of macular drusen in postmortem eyes. Am J Ophthalmol (1986) 1.11
The second eye of patients with senile macular degeneration. Arch Ophthalmol (1983) 1.07
Senile macular changes in the black African. Br J Ophthalmol (1978) 1.06
Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1986) 1.05
Growth features of choroidal neovascular membranes in age-related macular degeneration. Ophthalmology (1989) 1.04
Visual acuity related to retinal distance from the fovea in macular disease. Ann Ophthalmol (1984) 1.01
Retinal pigment epithelial cells release inhibitors of neovascularization. Ophthalmology (1987) 0.94
Subretinal neovascularization in senile macular degeneration. Am J Ophthalmol (1984) 0.91
Bilaterality of tears of the retinal pigment epithelium. Br J Ophthalmol (1988) 0.91
Aging macular degeneration. Clinical features of treatable disease. Ophthalmology (1985) 0.85
Identical twins with subretinal neovascularization complicating senile macular degeneration. Ophthalmic Surg (1985) 0.80
Macular degeneration and elevated serum ceruloplasmin. Invest Ophthalmol Vis Sci (1986) 0.79
Aging alterations of retina and choroid of Japanese: light microscopic study of macular region of 176 eyes. Jpn J Ophthalmol (1984) 0.78
Vision parameters in krypton and laser photocoagulation of subfoveal neovascular membranes. Ophthalmic Surg (1985) 0.78
Retracted Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial. Lancet (2000) 3.61
Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology (1996) 2.36
Simple retinal detachments: identifying the at-risk case. Eye (Lond) (2002) 2.26
Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (2000) 1.73
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Prophylactic argon laser retinopexy prior to removal of silicone oil: a pilot study. Eye (Lond) (1997) 1.67
Silicone oil removal. II. Operative and postoperative complications. Br J Ophthalmol (1987) 1.58
Pneumatic retinopexy in the treatment of primary rhegmatogenous retinal detachment. Eye (Lond) (1999) 1.47
The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond) (1998) 1.43
Surgical removal of choroidal neovascular membranes after laser photocoagulation for diabetic maculopathy. Eye (Lond) (2001) 1.38
Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. Br J Ophthalmol (1996) 1.35
Silicone oil removal. I. The effect on the complications of silicone oil. Br J Ophthalmol (1987) 1.30
Visual field loss following vitrectomy for stage 2 and 3 macular holes. Br J Ophthalmol (1996) 1.25
Systemic risk factors for idiopathic macular holes: a case-control study. Eye (Lond) (1998) 1.25
Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol (2000) 1.24
Macular microholes: pathogenesis and natural history. Br J Ophthalmol (2005) 1.22
Migrating scleral explants. Eye (Lond) (1992) 1.07
Retinitis pigmentosa and retinal neovascularization. Ophthalmology (1986) 1.06
Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology (1993) 1.05
Vanishing retinal arterial aneurysms: a case report. Br J Ophthalmol (1992) 1.01
Corneal astigmatism following cataract extraction. Br J Ophthalmol (1986) 1.01
Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol (2005) 1.01
A prospective study of the effect of a unilateral macular hole on sensory and motor binocular function and recovery following successful surgery. Br J Ophthalmol (2004) 1.00
Behçet's disease and interferon: flaws in research integrity of randomised trial. Lancet (2000) 0.99
Removal of silicone oil following diabetic vitrectomy. Br J Ophthalmol (1993) 0.97
Fundus autofluorescence in patients with macular holes imaged with a laser scanning ophthalmoscope. Br J Ophthalmol (1998) 0.94
Surgical treatment of full-thickness macular holes using autologous serum. Eye (Lond) (1996) 0.93
Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) (2006) 0.93
Visual and anatomical results of surgery for long standing macular holes. Br J Ophthalmol (2000) 0.93
Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study. Ophthalmology (1998) 0.92
Laser treatment of retinal angiomatosis. Eye (Lond) (1989) 0.89
Acute full-thickness macular hole after uncomplicated phacoemulsification cataract surgery. Am J Ophthalmol (2001) 0.88
Retained intravitreal lens fragments after phacoemulsification: a clinicopathological correlation. Br J Ophthalmol (1999) 0.88
Electroretinographic changes after vitrectomy and intraocular tamponade. Retina (1985) 0.87
Giant retinal tear and retinal detachment with underlying retinitis pigmentosa and hearing loss. Eye (Lond) (1996) 0.87
The surgical management of uveal effusion syndrome. Eye (Lond) (1987) 0.86
Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site. Eye (Lond) (1997) 0.86
Delayed suprachoroidal haemorrhage after glaucoma operations. Eye (Lond) (1989) 0.85
Membranectomy and autologous serum for the retreatment of full-thickness macular holes. Arch Ophthalmol (1997) 0.85
Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes. Br J Ophthalmol (1992) 0.84
Partial laser ablation of massive peripapillary subretinal neovascularization. Ophthalmology (1996) 0.83
Sympathetic ophthalmia associated with ocular and cerebral vasculitis: an angiographic and radiologic study. Eur J Ophthalmol (2003) 0.82
Immunocytochemical characterization of macular hole opercula. Arch Ophthalmol (2001) 0.82
Retinitis pigmentosa associated with peripheral sea fan neovascularization. Acta Ophthalmol Scand (2000) 0.82
Treatment of diffuse diabetic macular oedema: a comparison between argon and krypton lasers. Eye (Lond) (1990) 0.82
Cerebellar ataxia associated with hypogonadotropic hypogonadism and chorioretinopathy: a poorly recognized association. Clin Neurol Neurosurg (1994) 0.81
Juvenile coats disease associated with epiretinal membrane formation. Retina (1995) 0.81
Delayed fellow eye involvement in acute retinal necrosis syndrome. Am J Ophthalmol (1995) 0.80
Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy vs macular argon photocoagulation. Eye (Lond) (2005) 0.80
A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology (1999) 0.78
Retinal detachment in patients with proliferative sickle cell retinopathy. Trans Ophthalmol Soc U K (1986) 0.78
Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations. Eye (Lond) (2005) 0.78
Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease. Ann Ophthalmol (1991) 0.78
Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration: Pan-European experience. Eye (Lond) (2009) 0.78
Management of moderate to advanced Coats' disease. Ophthalmologica (1998) 0.77
Intraocular penetration of tamoxifen. Ophthalmology (2000) 0.76
Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes. Ger J Ophthalmol (1995) 0.76
Oestrogens and macular holes: a postal questionnaire. Eye (Lond) (1994) 0.76
Scedosporium apiospermum chorioretinitis. Acta Ophthalmol Scand (2001) 0.75
Intraocular injection of depomedrone. Br J Ophthalmol (1986) 0.75
Chorioretinal alterations in mucormycosis. Eye (Lond) (2001) 0.75
Sympathetic ophthalmia associated with ocular and cerebral vasculitis: An angiographic and radiologic study. Eur J Ophthalmol (2003) 0.75
Detection of prednisolone in vitreous following systemic administration. Eye (Lond) (1998) 0.75
Acquired peripheral retinal telangiectasia after retinal surgery. Retina (1994) 0.75
[Retinal vasculopathy associated with Berger's IgA nephropathy]. Klin Monbl Augenheilkd (2000) 0.75
Case of the month. Eur J Pediatr (1996) 0.75
Practice patterns of pneumatic retinopexy in the United Kingdom. Br J Ophthalmol (2001) 0.75
Subconjunctival injections of antibiotics are used increasingly at the conclusion of intraocular and extraocular procedures. Eye (Lond) (1989) 0.75
Pigment dispersion syndrome and butterfly-shaped pattern dystrophy of the retinal pigment epithelium. Eye (Lond) (2000) 0.75
Electrophysiological responses after vitrectomy and intraocular tamponade. Trans Ophthalmol Soc U K (1985) 0.75
Intraocular lymphoma--a case report. Cytopathology (1993) 0.75
Isolated retinal telangiectatic masses. Trans Ophthalmol Soc U K (1986) 0.75
Eales disease with internuclear ophthalmoplegia. Ann Ophthalmol (1992) 0.75
Blurred vision. Br J Hosp Med (1985) 0.75
The removal of silicone oil from the anterior chamber in phakic eyes. Arch Ophthalmol (1987) 0.75
Who should treat diabetic retinopathy? Eye (Lond) (1988) 0.75
Cases reported at the FAN club meeting, Bonn, November 1984. Case 3. Retinitis pigmentosa and retinal neovascularization. Int Ophthalmol (1985) 0.75
Macular holes viewed objectively. Br J Ophthalmol (1997) 0.75
Indirect argon laser drainage of subretinal fluid. Eye (Lond) (1996) 0.75